News

The Biorobot-Miniheart is pleased to announce the addition of Metatissue as its new partner.

Metatissue is focused on designing and manufacturing human protein-based products that find applications in in vitro cell culture, tissue engineering and regeneration, and disease modelling. The company was established to set the stage for a paradigm shift in cell culture and tissue modelling using human native proteins to create predictive and truly translatable 3D biological tissue models.

Metatissue will provide the Biorobot-Miniheart consortium a fully human based complex mixture of proteins and growth factors that can be crosslinked to form hydrogels and bioinks with controllable mechanical properties. These distinguished properties allow the design of heterogenous matrices to create living machines with a local control over stiffness and elasticity, which will be explored together with the BioRobot-MiniHeart partners.

Catarina Custódio, Co-Founder & CEO of Metatissue, mentioned, “Until now, there are no cost-effective, scalable, and sustainable 3D cardiac tissue models available that closely mimic the native microenvironment. This is due to complications associated with generating human-ECM mimicking materials for 3D cell cultures. By combining our expertise with that of the Biorobot-Miniheart partners, I strongly believe that this Hop-on could offer the most promising possibility of developing reliable models and improving the capabilities of the ‘living’ micro-machines, sensors, and actuators with controllable mechanical properties that have been under development since the project’s inception.”